Greg Malnassy

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

Wendy Stock, Selina M. Luger, Anjali S. Advani et al. · Blood · 2019 · 454 citations · Full text

A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia

Jerald P. Radich, Kenneth J. Kopecky, Frederick R. Appelbaum et al. · Blood · 2012 · 174 citations · Full text

Favorable Outcomes for Older Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL): Early Results of U.S. Intergroup Trial C10403

Wendy Stock, Selina M. Luger, Anjali S. Advani et al. · Blood · 2014 · 105 citations

Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102).

Wendy Stock, Ben L. Sanford, Gerard Lozanski et al. · Blood · 2009 · 64 citations

Integrin subunit beta 8 contributes to lenvatinib resistance in HCC

Wei Hou, Bryan Bridgeman, Greg Malnassy et al. · Hepatology Communications · 2022 · 46 citations · Full text